Functional selectivity of adenosine A1 receptor ligands?

Purinergic Signalling

Volumn 9, Issue 1, 2013, Pages 91-100

  Langemeijer, Ellen V ^a   Verzijl, Dennis ^a   Dekker, Stefan J ^a   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine; Beta arrestin; Biased signaling; Functional selectivity; GTP S

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATE; LIGAND;

ANIMAL CELL; ARTICLE; BINDING ASSAY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DETERMINATION; RADIOASSAY; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SCREENING; SIGNAL TRANSDUCTION;

EID: 84873749973     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9334-3     Document Type: Article

References (38)

1. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63(1): 1-34. doi: 10. 1124/pr. 110. 003285.
2. Verzijl D, IJzerman AP (2011) Functional selectivity of adenosine receptor ligands. Purinergic Signal 7(2): 171-192. doi: 10. 1007/s11302-011-9232-0.
3. Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9(5): 373-386. doi: 10. 1038/nrd3024.
4. Patel CB, Noor N, Rockman HA (2010) Functional selectivity in adrenergic and angiotensin signaling systems. Mol Pharmacol 78(6): 983-992. doi: 10. 1124/mol. 110. 067066.
5. Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336(2): 296-302. doi: 10. 1124/jpet. 110. 173948.
6. Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 17(3): 126-139. doi: 10. 1016/j. molmed. 2010. 11. 004.
7. 1 receptors. Eur J Pharmacol 522(1-3): 1-8. doi: 10. 1016/j. ejphar. 2005. 08. 052.
8. 3 receptors. J Med Chem 44(18): 2966-2975.
9. 3 adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways. Pharmacol Res 57(4): 303-311. doi: 10. 1016/j. phrs. 2008. 02. 008.
10. 3 receptor subtypes. Bioorg Med Chem Lett 10(18): 2141-2144.
11. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, Kloss B, Axel R, Lee KJ (2008) The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A 105(1): 64-69. doi: 10. 1073/pnas. 0710487105.
12. Klaasse EC, IJzerman AP, de Grip WJ, Beukers MW (2008) Internalization and desensitization of adenosine receptors. Purinergic Signal 4(1): 21-37. doi: 10. 1007/s11302-007-9086-7.
13. 3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. BMC Pharmacol 8: 20. doi: 10. 1186/1471-2210-8-20.
14. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52: 179-197. doi: 10. 1146/annurev. pharmtox. 010909. 105800.
15. Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM, Violin JD, Lefkowitz RJ (2011) Quantifying ligand bias at seven-transmembrane receptors. Mol Pharmacol 80(3): 367-377. doi: 10. 1124/mol. 111. 072801.
16. Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, Lefkowitz RJ (2008) Beta-arrestin-biased agonism at the beta2-adrenergic receptor. J Biol Chem 283(9): 5669-5676. doi: 10. 1074/jbc. M708118200.
17. Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17(4): 159-165. doi: 10. 1016/j. tem. 2006. 03. 008.
18. 1 receptor. Bioorg Med Chem 12(1): 139-149.
19. 1 receptor. J Med Chem 48(6): 2045-2053. doi: 10. 1021/jm049597+.
20. van Veldhoven JP, Chang LC, von Frijtag Drabbe Kunzel JK, Mulder-Krieger T, Struensee-Link R, Beukers MW, Brussee J, IJzerman AP (2008) A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines. Bioorg Med Chem 16(6): 2741-2752. doi: 10. 1016/j. bmc. 2008. 01. 013.
21. 1 receptor antagonists. J Med Chem 47(26): 6529-6540. doi: 10. 1021/jm049448r.
22. Chang LC, Spanjersberg RF, von Frijtag Drabbe Kunzel JK, Mulder-Krieger T, Brussee J, IJzerman AP (2006) 2, 6-disubstituted and 2, 6, 8-trisubstituted purines as adenosine receptor antagonists. J Med Chem 49(10): 2861-2867. doi: 10. 1021/jm050640i.
23. Chang LC, von Frijtag Drabbe Kunzel JK, Mulder-Krieger T, Westerhout J, Spangenberg T, Brussee J, IJzerman AP (2007) 2, 6, 8-trisubstituted 1-deazapurines as adenosine receptor antagonists. J Med Chem 50(4): 828-834. doi: 10. 1021/jm0607956.
24. 1 receptor. Biochem Pharmacol 80(8): 1180-1189. doi: 10. 1016/j. bcp. 2010. 06. 041.
25. Göblyös A, Santiago SN, Pietra D, Mulder-Krieger T, von Frijtag Drabbe Kunzel J, Brussee J, IJzerman AP (2005) Synthesis and biological evaluation of 2-aminothiazoles and their amide derivatives on human adenosine receptors. Lack of effect of 2-aminothiazoles as allosteric enhancers. Bioorg Med Chem 13(6): 2079-2087. doi: 10. 1016/j. bmc. 2005. 01. 006.
26. 3 receptor. J Med Chem 45(2): 420-429.
27. 1 receptor. Bioorg Med Chem Lett 11(15): 2017-2019.
28. 2A adenosine receptor antagonists. J Med Chem 51(15): 4449-4455. doi: 10. 1021/jm701594y.
29. 2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine. J Med Chem 47(15): 3707-3709. doi: 10. 1021/jm049947s.
30. van Muijlwijk-Koezen JE, Timmerman H, Vollinga RC, Frijtag von Drabbe Kunzel J, de Groote M, Visser S, IJzerman AP (2001) Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. J Med Chem 44(5): 749-762.
31. 1 receptor. J Med Chem 46(8): 1492-1503. doi: 10. 1021/jm021074j.
32. 2A receptor. Bioorg Med Chem 11(10): 2183-2192.
33. 3 receptor. J Med Chem 43(11): 2227-2238.
34. 3 receptor ligands. 1. 3-(2-pyridinyl)isoquinoline derivatives. J Med Chem 41(21): 3987-3993. doi: 10. 1021/jm980036q.
35. 3 receptor. J Med Chem 42(8): 1393-1400. doi: 10. 1021/jm981090+.
36. 1 receptor-binding activity, and chromone and dihydronaphthalenone constituents from Senna siamea. J Nat Prod 63(3): 315-317.
37. 3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. J Med Chem 41(21): 3994-4000. doi: 10. 1021/jm980037i.
38. 3 receptor subtypes. J Med Chem 41(15): 2835-2845. doi: 10. 1021/jm980094b.